The GMP Letter
March 2012
Missing, Flawed MDR Procedures Land Warning for UK Company
A British cardiac device company earned an FDA warning letter over its failure to establish medical device reporting (MDR) procedures.
This article is viewable by subscribers only. To view this article, please select an option below.
|